Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
151,865,218
-
Total 13F shares
-
133,191,971
-
Share change
-
+1,336,816
-
Total reported value
-
$1,173,602,347
-
Put/Call ratio
-
8.6%
-
Price per share
-
$8.83
-
Number of holders
-
219
-
Value change
-
+$16,706,318
-
Number of buys
-
108
-
Number of sells
-
82
Institutional Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q1 2023
As of 31 Mar 2023,
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) was held by
219 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
133,191,971 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC, BlackRock Inc., Matrix Capital Management Company, LP, ARK Investment Management LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., Blue Water Life Science Advisors, LP, STATE STREET CORP, and MASSACHUSETTS FINANCIAL SERVICES CO /MA/.
This page lists
220
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.